- Joined
- May 19, 2019
- Messages
- 483
- Reaction score
- 861
Anesthesia resident here.
In regards to bradycardia, when would you use atropine vs glycopyrrolate and why?
My understanding is glycopyrrolate doesn’t cross BBB so it is generally the preferred agent in the OR for mild bradycardia, especially in the elderly.
What if the patient has severe bradycardia? I’ve had a couple instances when the patient has a sudden and brief run of asystole for about 10 seconds. By the time I grab the epinephrine, the heart rate has recovered to ~30 bpm. In one instance, the patient had an art line and had a normal BP. On the other, they had a BP cuff, so I didn’t know what the BP was at that time. In both cases I gave 0.4 mg of atropine. I chose atropine because it’s in the ACLS algorithm, so presumably it must be better than glycopyrrolate in this scenario. I chose 0.4 mg because that’s what in the vial.
Another question. I’ve heard that low doses of glycopyrrolate can cause bradycardia. Is this true? What about atropine? What dose is preferred?
Final question, if the patient is pregnant and bradycardic, do you choose atropine or glycopyrrolate given the differences in placental transfer? Do you give sugammadex in a pregnant or breastfeeding patient? If not, do you use atropine or glyco to counteract the bradycardia from neostigmine in a pregnant lady?
In regards to bradycardia, when would you use atropine vs glycopyrrolate and why?
My understanding is glycopyrrolate doesn’t cross BBB so it is generally the preferred agent in the OR for mild bradycardia, especially in the elderly.
What if the patient has severe bradycardia? I’ve had a couple instances when the patient has a sudden and brief run of asystole for about 10 seconds. By the time I grab the epinephrine, the heart rate has recovered to ~30 bpm. In one instance, the patient had an art line and had a normal BP. On the other, they had a BP cuff, so I didn’t know what the BP was at that time. In both cases I gave 0.4 mg of atropine. I chose atropine because it’s in the ACLS algorithm, so presumably it must be better than glycopyrrolate in this scenario. I chose 0.4 mg because that’s what in the vial.
Another question. I’ve heard that low doses of glycopyrrolate can cause bradycardia. Is this true? What about atropine? What dose is preferred?
Final question, if the patient is pregnant and bradycardic, do you choose atropine or glycopyrrolate given the differences in placental transfer? Do you give sugammadex in a pregnant or breastfeeding patient? If not, do you use atropine or glyco to counteract the bradycardia from neostigmine in a pregnant lady?